NZ596844A - Monolithic intravaginal rings comprising progesterone and methods of making and uses thereof - Google Patents

Monolithic intravaginal rings comprising progesterone and methods of making and uses thereof

Info

Publication number
NZ596844A
NZ596844A NZ596844A NZ59684409A NZ596844A NZ 596844 A NZ596844 A NZ 596844A NZ 596844 A NZ596844 A NZ 596844A NZ 59684409 A NZ59684409 A NZ 59684409A NZ 596844 A NZ596844 A NZ 596844A
Authority
NZ
New Zealand
Prior art keywords
progesterone
weight
ring
monolithic intravaginal
pharmaceutically acceptable
Prior art date
Application number
NZ596844A
Other languages
English (en)
Inventor
Salah U Ahmed
Jiaxiang Tsao
Anu Mahashabde
Diane D Harrison
Original Assignee
Teva Women’S Health Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=40939073&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NZ596844(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Teva Women’S Health Inc filed Critical Teva Women’S Health Inc
Priority to NZ61126809A priority Critical patent/NZ611268A/en
Publication of NZ596844A publication Critical patent/NZ596844A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F6/00—Contraceptive devices; Pessaries; Applicators therefor
    • A61F6/06—Contraceptive devices; Pessaries; Applicators therefor for use by females
    • A61F6/14—Contraceptive devices; Pessaries; Applicators therefor for use by females intra-uterine type
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F6/00—Contraceptive devices; Pessaries; Applicators therefor
    • A61F6/06—Contraceptive devices; Pessaries; Applicators therefor for use by females
    • A61F6/08—Pessaries, i.e. devices worn in the vagina to support the uterus, remedy a malposition or prevent conception, e.g. combined with devices protecting against contagion
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
    • A61K9/0036—Devices retained in the vagina or cervix for a prolonged period, e.g. intravaginal rings, medicated tampons, medicated diaphragms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/06—Antiabortive agents; Labour repressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18—Feminine contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/06—Drugs for disorders of the endocrine system of the anterior pituitary hormones, e.g. TSH, ACTH, FSH, LH, PRL, GH
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/34—Gestagens
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B29—WORKING OF PLASTICS; WORKING OF SUBSTANCES IN A PLASTIC STATE IN GENERAL
    • B29C—SHAPING OR JOINING OF PLASTICS; SHAPING OF MATERIAL IN A PLASTIC STATE, NOT OTHERWISE PROVIDED FOR; AFTER-TREATMENT OF THE SHAPED PRODUCTS, e.g. REPAIRING
    • B29C45/00—Injection moulding, i.e. forcing the required volume of moulding material through a nozzle into a closed mould; Apparatus therefor
    • B29C45/0001—Injection moulding, i.e. forcing the required volume of moulding material through a nozzle into a closed mould; Apparatus therefor characterised by the choice of material
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B29—WORKING OF PLASTICS; WORKING OF SUBSTANCES IN A PLASTIC STATE IN GENERAL
    • B29C—SHAPING OR JOINING OF PLASTICS; SHAPING OF MATERIAL IN A PLASTIC STATE, NOT OTHERWISE PROVIDED FOR; AFTER-TREATMENT OF THE SHAPED PRODUCTS, e.g. REPAIRING
    • B29C45/00—Injection moulding, i.e. forcing the required volume of moulding material through a nozzle into a closed mould; Apparatus therefor
    • B29C45/17—Component parts, details or accessories; Auxiliary operations
    • B29C45/72—Heating or cooling
    • B29C45/7207—Heating or cooling of the moulded articles
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B29—WORKING OF PLASTICS; WORKING OF SUBSTANCES IN A PLASTIC STATE IN GENERAL
    • B29K—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES B29B, B29C OR B29D, RELATING TO MOULDING MATERIALS OR TO MATERIALS FOR MOULDS, REINFORCEMENTS, FILLERS OR PREFORMED PARTS, e.g. INSERTS
    • B29K2083/00—Use of polymers having silicon, with or without sulfur, nitrogen, oxygen, or carbon only, in the main chain, as moulding material
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B29—WORKING OF PLASTICS; WORKING OF SUBSTANCES IN A PLASTIC STATE IN GENERAL
    • B29K—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES B29B, B29C OR B29D, RELATING TO MOULDING MATERIALS OR TO MATERIALS FOR MOULDS, REINFORCEMENTS, FILLERS OR PREFORMED PARTS, e.g. INSERTS
    • B29K2105/00—Condition, form or state of moulded material or of the material to be shaped
    • B29K2105/0005—Condition, form or state of moulded material or of the material to be shaped containing compounding ingredients
    • B29K2105/0035—Medical or pharmaceutical agents
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B29—WORKING OF PLASTICS; WORKING OF SUBSTANCES IN A PLASTIC STATE IN GENERAL
    • B29L—INDEXING SCHEME ASSOCIATED WITH SUBCLASS B29C, RELATING TO PARTICULAR ARTICLES
    • B29L2031/00—Other particular articles
    • B29L2031/753—Medical equipment; Accessories therefor

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Reproductive Health (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Endocrinology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Diabetes (AREA)
  • Manufacturing & Machinery (AREA)
  • Mechanical Engineering (AREA)
  • Urology & Nephrology (AREA)
  • Pregnancy & Childbirth (AREA)
  • Inorganic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Orthopedics, Nursing, And Contraception (AREA)
  • Media Introduction/Drainage Providing Device (AREA)
  • Surgical Instruments (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
NZ596844A 2008-02-04 2009-02-03 Monolithic intravaginal rings comprising progesterone and methods of making and uses thereof NZ596844A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
NZ61126809A NZ611268A (en) 2008-02-04 2009-02-03 Monolithic intravaginal rings comprising progesterone and methods of making and uses thereof

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US2611508P 2008-02-04 2008-02-04
US13945408P 2008-12-19 2008-12-19
NZ587758A NZ587758A (en) 2008-02-04 2009-02-03 Monolithic intravaginal rings comprising progesterone and methods of making and uses thereof
PCT/US2009/000672 WO2009099586A2 (en) 2008-02-04 2009-02-03 Monolithic intravaginal rings comprising progesterone and methods of making and uses thereof

Publications (1)

Publication Number Publication Date
NZ596844A true NZ596844A (en) 2014-03-28

Family

ID=40939073

Family Applications (3)

Application Number Title Priority Date Filing Date
NZ596844A NZ596844A (en) 2008-02-04 2009-02-03 Monolithic intravaginal rings comprising progesterone and methods of making and uses thereof
NZ61126809A NZ611268A (en) 2008-02-04 2009-02-03 Monolithic intravaginal rings comprising progesterone and methods of making and uses thereof
NZ587758A NZ587758A (en) 2008-02-04 2009-02-03 Monolithic intravaginal rings comprising progesterone and methods of making and uses thereof

Family Applications After (2)

Application Number Title Priority Date Filing Date
NZ61126809A NZ611268A (en) 2008-02-04 2009-02-03 Monolithic intravaginal rings comprising progesterone and methods of making and uses thereof
NZ587758A NZ587758A (en) 2008-02-04 2009-02-03 Monolithic intravaginal rings comprising progesterone and methods of making and uses thereof

Country Status (26)

Country Link
US (5) US8580293B2 (enExample)
EP (2) EP2359807B1 (enExample)
JP (2) JP5507467B2 (enExample)
KR (3) KR20100133969A (enExample)
CN (2) CN104146948B (enExample)
AR (1) AR070561A1 (enExample)
AU (1) AU2009210779B2 (enExample)
BR (1) BRPI0905946B8 (enExample)
CA (2) CA2713943C (enExample)
CL (1) CL2009000242A1 (enExample)
DK (2) DK2359807T3 (enExample)
EA (2) EA021615B1 (enExample)
ES (2) ES2645630T3 (enExample)
HR (1) HRP20171319T1 (enExample)
HU (1) HUE035634T2 (enExample)
IL (2) IL207376A (enExample)
LT (1) LT2249757T (enExample)
MX (2) MX385981B (enExample)
NZ (3) NZ596844A (enExample)
PL (2) PL2249757T3 (enExample)
PT (2) PT2359807T (enExample)
SG (2) SG10201605171QA (enExample)
SI (2) SI2359807T1 (enExample)
TW (3) TWI599359B (enExample)
WO (1) WO2009099586A2 (enExample)
ZA (2) ZA201307321B (enExample)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
LT2249757T (lt) 2008-02-04 2017-09-25 Ferring B.V. Vientisi intravaginaliniai žiedai, apimantys progesteroną, ir jų gamybos bei panaudojimo būdai
JP2013535992A (ja) * 2010-06-22 2013-09-19 テバ ウィメンズ ヘルス インコーポレイテッド 抗コリン作動剤を含む膣内用デバイスおよびそれを作る方法
US8580294B2 (en) 2010-10-19 2013-11-12 International Partnership For Microbicides Platinum-catalyzed intravaginal rings
EP2641602A1 (en) * 2012-03-23 2013-09-25 PregLem S.A. Method for treating gynecological diseases
WO2014122563A1 (en) * 2013-02-08 2014-08-14 Qpharma Ab An intra vaginal device, and a method of reducing the rate of diffusion of active ingredients in said intra vaginal device
CN103394127A (zh) * 2013-08-02 2013-11-20 苏州市马尔泰新材料有限公司 一种含有中西医药的阴道模具材料
CN103431930A (zh) * 2013-08-02 2013-12-11 苏州市马尔泰新材料有限公司 一种含有甲酯树脂的阴道模具
CN103394128A (zh) * 2013-08-02 2013-11-20 苏州市马尔泰新材料有限公司 一种含有川芎的模具材料
CN103405810A (zh) * 2013-08-02 2013-11-27 苏州市马尔泰新材料有限公司 一种含有甲基丙烯酸甲酯树脂的阴道模具
CN103445892A (zh) * 2013-08-02 2013-12-18 苏州市马尔泰新材料有限公司 一种含有甲酯树脂和雌酚的阴道模具
US10137031B2 (en) 2013-11-14 2018-11-27 International Partnership For Microbicides, Inc. Combination therapy intravaginal rings
CN112494195A (zh) 2014-04-01 2021-03-16 保利医学公司 避孕装置及相关装置
ES2699003T3 (es) * 2014-06-28 2019-02-06 Laboratorios Andromaco S A Pesario de cerclaje que contiene progesterona de liberación prolongada, sostenida y continua, usado para la prevención de partos prematuros
CN104546267B (zh) * 2015-01-13 2017-01-04 安徽农业大学 一种犬用宫外节育装置及其节育方法
BR112018012744A2 (pt) * 2015-12-21 2018-12-04 Bayer Oy método de fabricação de um anel vaginal
EP3542786A1 (en) * 2018-03-21 2019-09-25 ITF Research Pharma, S.L.U. Progesterone intravaginal devices
CN114126710A (zh) * 2019-03-29 2022-03-01 B·马特尔 含有孕酮的eva分段式阴道内环
US10918649B2 (en) 2019-06-21 2021-02-16 The Population Council, Inc. System for providing birth control
US11439588B2 (en) * 2019-10-12 2022-09-13 National Research Institute For Family Planning Vaginal sustained-release drug delivery system for luteal support, method for preparation and use thereof
TWI791347B (zh) * 2020-12-11 2023-02-01 酷氏基因生物科技股份有限公司 一種用於評估胚胎植入成功率的預測方法

Family Cites Families (70)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE494972A (enExample) 1949-04-07
US2863846A (en) 1950-05-04 1958-12-09 Dow Corning Organo silyl-silica filled siloxane elastomers and process for producing same
US2890188A (en) 1951-12-17 1959-06-09 Dow Corning Siloxane elastomers compounded with hydroxylated silanes
NL91756C (enExample) 1953-11-19
US3022951A (en) 1957-05-14 1962-02-27 Ibm Full adder
US3545439A (en) 1968-01-04 1970-12-08 Upjohn Co Medicated devices and methods
US3948262A (en) * 1969-04-01 1976-04-06 Alza Corporation Novel drug delivery device
US3854480A (en) * 1969-04-01 1974-12-17 Alza Corp Drug-delivery system
IL48277A (en) * 1974-10-18 1978-03-10 Schering Ag Vaginal ring
DE3040978A1 (de) * 1980-10-28 1982-05-27 Schering Ag, 1000 Berlin Und 4619 Bergkamen Vaginalring
US4629449A (en) * 1982-07-29 1986-12-16 Alza Corporation Vaginal dispenser for dispensing beneficial hormone
US4816257A (en) * 1985-09-20 1989-03-28 Research & Education Institute, Harbor-Ucla Medical Center Inc. Method for producing an in vivo environment suitable for human embryo transfer
SE8602666D0 (sv) * 1986-06-16 1986-06-16 Leo Ab Intravaginal devices
US5188835A (en) * 1986-06-16 1993-02-23 Kabi Pharmacia Ab Intravaginal devices
FR2618329B1 (fr) 1987-07-22 1997-03-28 Dow Corning Sa Procede de fabrication d'un anneau capable d'assurer la liberation d'un agent therapeutique, et anneau fabrique par ce procede
US5116619A (en) * 1988-08-30 1992-05-26 Lee Roy Morgan Vaginal progesterone tablet
US5084277A (en) * 1988-08-30 1992-01-28 Greco John C Vaginal progesterone tablet
DE3838815A1 (de) * 1988-11-17 1990-05-23 Hoechst Ag Verfahren zum herstellen eines intravaginalen applikationssystems
US6264638B1 (en) * 1989-12-07 2001-07-24 Ultrafem, Inc. Intravaginal drug delivery system and discharge collection device
US5340585A (en) * 1991-04-12 1994-08-23 University Of Southern California Method and formulations for use in treating benign gynecological disorders
US5393528A (en) * 1992-05-07 1995-02-28 Staab; Robert J. Dissolvable device for contraception or delivery of medication
IT1256393B (it) 1992-11-17 1995-12-04 Inverni Della Beffa Spa Forme matriciali multistrato per il rilascio controllato di principi attivi
FI95768C (fi) * 1993-06-17 1996-03-25 Leiras Oy Emättimensisäinen antosysteemi
US5543150A (en) * 1993-09-15 1996-08-06 Columbia Laboratories, Inc. Method of progesterone delivery and affect thereof
US6586006B2 (en) * 1994-08-04 2003-07-01 Elan Drug Delivery Limited Solid delivery systems for controlled release of molecules incorporated therein and methods of making same
EP0836473B1 (en) * 1995-07-04 2001-10-31 Akzo Nobel N.V. Ring-shaped devices
GB9522403D0 (en) * 1995-11-01 1996-01-03 Hoechst Roussel Ltd Intravaginal drug delivery device
US5744463A (en) * 1996-06-03 1998-04-28 Bair; Glenn O. Treatment of side effects of progestins and progesterone analogues used for birth control
US5869081A (en) * 1996-06-28 1999-02-09 The Population Council Progesterone vaginal ring for treatment of infertility
US5972372A (en) * 1996-07-31 1999-10-26 The Population Council, Inc. Intravaginal rings with insertable drug-containing core
US6028064A (en) * 1996-09-13 2000-02-22 New Life Pharmaceuticals Inc. Prevention of ovarian cancer by administration of progestin products
US5985861A (en) * 1996-11-04 1999-11-16 Columbia Laboratories, Inc. Progesterone for treating or reducing ischemia
US5814329A (en) * 1996-11-12 1998-09-29 Polytherapeutics, Inc. Hydrophilic polystyrene graft copolymer vehicle for intravaginal administration of pharmacologically active agents
US6416778B1 (en) * 1997-01-24 2002-07-09 Femmepharma Pharmaceutical preparations and methods for their regional administration
US5993856A (en) * 1997-01-24 1999-11-30 Femmepharma Pharmaceutical preparations and methods for their administration
US6056972A (en) * 1997-02-26 2000-05-02 Dimera, Llc Method for reducing coronary artery reactivity
NZ501236A (en) * 1997-05-07 2002-02-01 Galen Chemicals Ltd Intravaginal drug delivery devices for the administration of testosterone and testosterone precursors in a polymer matrix and surrounded by a sheath
US6197327B1 (en) * 1997-06-11 2001-03-06 Umd, Inc. Device and method for treatment of dysmenorrhea
US6039968A (en) 1997-06-24 2000-03-21 Hoechst Marion Roussel Intravaginal drug delivery device
US6245757B1 (en) * 1997-10-03 2001-06-12 Research Corporation Technologies, Inc. Use of progestins to treat ischemic event
US6306914B1 (en) * 1997-10-21 2001-10-23 Columbia Laboratories, Inc. Progestin therapy for maintaining amenorrhea
NZ330596A (en) * 1998-06-05 2001-02-23 Dec Res Intravaginal devices allowing for increased uptake of active ingredients
AU748653B2 (en) * 1998-05-01 2002-06-06 John F. Cline Method for injection molding manufacture of controlled release devices
JP2002518351A (ja) 1998-06-19 2002-06-25 オキシバイオ・インコーポレイテッド 抗感染および避妊特性を有する医療装置
US7001609B1 (en) * 1998-10-02 2006-02-21 Regents Of The University Of Minnesota Mucosal originated drug delivery systems and animal applications
US6056976A (en) 1998-11-12 2000-05-02 Leiras Oy Elastomer, its preparation and use
US6063395A (en) 1998-11-12 2000-05-16 Leiras Oy Drug delivery device especially for the delivery of progestins and estrogens
US20050197651A1 (en) * 2001-04-25 2005-09-08 Chen Hai L. Vaginal ring preparation and its application
CN1210079C (zh) * 2001-04-25 2005-07-13 上海市计划生育科学研究所 阴道环制剂及其应用
AU2002313517B2 (en) * 2001-08-31 2007-09-06 Bayer Schering Pharma Oy Drug delivery system
AU2003208679A1 (en) * 2002-02-08 2003-09-02 Advanced Animal Technology Limited Control of a biological function
EP1494646B2 (en) * 2002-03-27 2017-10-04 Warner Chilcott (Ireland) Limited Intravaginal matrix drug delivery devices
CA2504283A1 (en) * 2002-10-31 2004-05-21 Umd, Inc. Therapeutic compositions for drug delivery to and through covering epithelia
US20040089308A1 (en) * 2002-11-13 2004-05-13 Welch Robert A. Cervical ring to deliver medication
FR2849380A1 (fr) * 2002-12-27 2004-07-02 Ernest Loumaye NOUVELLE UTILISATION D'UN AGONISTE DU GnRH
ATE461681T1 (de) * 2003-04-29 2010-04-15 Gen Hospital Corp Verfahren und vorrichtungen für die verzögerte freisetzung von mehreren arzneimitteln
US8404272B2 (en) * 2003-06-26 2013-03-26 Poly-Med, Inc. Fiber-reinforced composite rings for intravaginal controlled drug delivery
CA2531640C (en) * 2003-07-10 2013-06-18 Galen (Chemicals) Limited Intravaginal drug delivery devices
US20050255157A1 (en) * 2004-05-11 2005-11-17 Glenmark Pharmaceuticals Limited Sustained release, mucoadhesive vaginal pharmaceutical compositions
US7707169B2 (en) 2004-06-10 2010-04-27 Siemens Corporation Specification-based automation methods for medical content extraction, data aggregation and enrichment
KR101229701B1 (ko) * 2004-07-09 2013-02-05 라보라토이레 에이치알에이 파르마 프로게스테론 수용체 조절제를 함유하는 서방형 조성물
AR043476A1 (es) * 2004-09-09 2005-08-03 Dvoskin Victor Oscar Dispositivo de administracion regulada de sustancias para la insercion en una cavidad corporal y procedimiento para fabricar un medio de soporte de dichas sustancias
US7517914B2 (en) * 2005-04-04 2009-04-14 Boston Scientificscimed, Inc. Controlled degradation materials for therapeutic agent delivery
US8399012B2 (en) * 2006-04-17 2013-03-19 Kimberly-Clark Worldwide, Inc. Degradable therapeutic delivery device
JP2009536164A (ja) * 2006-05-10 2009-10-08 エボニック デグサ ゲーエムベーハー ロール圧密成形した熱分解法二酸化ケイ素の医薬組成物での使用
US8828981B2 (en) * 2007-02-06 2014-09-09 George Creasy Progesterone for the treatment or prevention of spontaneous preterm birth
US20080214512A1 (en) * 2007-03-01 2008-09-04 Christian Seitz Pharmaceutical preparation containing a gestagen, and kit and method for treating endometriosis using the preparation
CA2823407C (en) * 2007-03-22 2016-10-18 Berg Pharma Llc Topical formulations having enhanced bioavailability
WO2008140794A1 (en) 2007-05-11 2008-11-20 The Texas A & M University System Hormone normalization therapy and uses thereof
LT2249757T (lt) 2008-02-04 2017-09-25 Ferring B.V. Vientisi intravaginaliniai žiedai, apimantys progesteroną, ir jų gamybos bei panaudojimo būdai

Also Published As

Publication number Publication date
CN104146948A (zh) 2014-11-19
CA2713943C (en) 2018-10-23
US20160279147A1 (en) 2016-09-29
CN102098991A (zh) 2011-06-15
ES2645630T3 (es) 2017-12-07
CL2009000242A1 (es) 2010-01-04
CN104146948B (zh) 2018-01-02
JP5507467B2 (ja) 2014-05-28
IL207376A (en) 2012-09-24
KR20100133969A (ko) 2010-12-22
EP2249757B1 (en) 2017-08-09
CA2713943A1 (en) 2009-08-13
IL207376A0 (en) 2010-12-30
US8580293B2 (en) 2013-11-12
SI2249757T1 (sl) 2017-10-30
PL2359807T3 (pl) 2017-12-29
US20140030311A1 (en) 2014-01-30
AR070561A1 (es) 2010-04-21
EA201491815A1 (ru) 2015-03-31
EA201070919A1 (ru) 2011-04-29
BRPI0905946B1 (pt) 2020-09-29
SG187529A1 (en) 2013-02-28
BRPI0905946B8 (pt) 2021-05-25
EP2359807A1 (en) 2011-08-24
JP6124411B2 (ja) 2017-05-10
ZA201307321B (en) 2017-09-27
AU2009210779B2 (en) 2015-04-02
EA021615B1 (ru) 2015-07-30
HRP20171319T1 (hr) 2017-10-20
JP2011510984A (ja) 2011-04-07
ES2648640T3 (es) 2018-01-04
EP2359807B1 (en) 2017-07-26
KR101730517B1 (ko) 2017-04-26
DK2249757T3 (en) 2017-10-16
PL2249757T3 (pl) 2017-12-29
NZ587758A (en) 2012-05-25
JP2014167001A (ja) 2014-09-11
CN102098991B (zh) 2014-10-22
ZA201307320B (en) 2017-03-29
CA3016642A1 (en) 2009-08-13
SG10201605171QA (en) 2016-08-30
DK2359807T3 (en) 2017-10-16
MX385981B (es) 2025-03-04
US20200405732A1 (en) 2020-12-31
EA031017B1 (ru) 2018-11-30
US11413294B2 (en) 2022-08-16
WO2009099586A3 (en) 2010-01-14
EP2249757A2 (en) 2010-11-17
IL221988A (en) 2015-03-31
TWI655947B (zh) 2019-04-11
MX2010008545A (es) 2010-12-20
HUE035634T2 (en) 2018-05-28
AU2009210779A1 (en) 2009-08-13
US20230158044A1 (en) 2023-05-25
MX337634B (es) 2016-03-14
EP2249757A4 (en) 2011-07-20
LT2249757T (lt) 2017-09-25
PT2359807T (pt) 2017-11-07
TWI549681B (zh) 2016-09-21
US20090202612A1 (en) 2009-08-13
TW201526898A (zh) 2015-07-16
BRPI0905946A2 (pt) 2015-06-30
KR20160055980A (ko) 2016-05-18
TWI599359B (zh) 2017-09-21
KR20140048321A (ko) 2014-04-23
PT2249757T (pt) 2017-11-15
SI2359807T1 (sl) 2017-10-30
NZ611268A (en) 2015-03-27
WO2009099586A2 (en) 2009-08-13
US10548904B2 (en) 2020-02-04
TW201630610A (zh) 2016-09-01
TW200938204A (en) 2009-09-16
US10537584B2 (en) 2020-01-21

Similar Documents

Publication Publication Date Title
NZ596844A (en) Monolithic intravaginal rings comprising progesterone and methods of making and uses thereof
NZ606825A (en) Methods and compositions for treating complement-associated disorders
US20230355687A1 (en) Ammonia oxidizing microorganisms for use and delivery to the urogenital system
RU2020140867A (ru) Капсулы с растворимым эстрадиолом для интравагинального введения
EA201270221A1 (ru) Лечение болезни крона с применением лаквинимода
JP2011510984A5 (enExample)
GB201113728D0 (en) Inflammatory disease
EP1731177A4 (en) BIOLOGICAL TISSUE SHEET, METHOD OF FORMATION THEREOF AND TRANSPLANTATION METHOD USING THE SHEET
JP2014530242A (ja) 皮膚疾病の処置用のケメリンｃ１５ペプチドの局所製剤
WO2010082787A2 (ko) 연골줄기세포를 유효성분으로 포함하는 골질환 치료용 또는 항염증용 약제학적 조성물
NZ612717A (en) Treatment of pain associated with dislocation of basal endometrium
NO20076382L (no) Anvendelse av dokosaheksaenglyserider i behandlingen av tumorese sykdommer
EA201491614A1 (ru) Способ лечения гинекологических заболеваний
RU2011138963A (ru) Метаболиты, являющиеся церамидными аналогами
US20070110805A1 (en) Modified-release pharmaceutical compositions
EP2583966A4 (en) TRICARBONYL TECHNETIUM 99M OR RHENIUM 188 MARKING RING RGD DERIVATIVE, METHOD OF PREPARING THEREOF, AND PHARMACEUTICAL COMPOSITION COMPRISING THE DERIVATIVE AS AN ACTIVE INGREDIENT FOR USE IN THE DIAGNOSIS OR TREATMENT OF ANGIOGENIC ASSOCIATED DISEASES
EP2525819A4 (en) IMMUNOTHERAPY COMPOSITIONS AND TREATMENT PROCEDURES
MX2008015323A (es) Composicion farmaceutica que comprende ciclobenzaprina y aceclofenac en asociacion.
White et al. Effects of naproxcinod on blood pressure in patients with osteoarthritis
CN104324018B (zh) 广藿香醇在制备男性性功能障碍药物或保健品中的应用
JP5630264B2 (ja) 膀胱排尿筋収縮および尿道括約筋弛緩剤
MY162654A (en) Pharmaceutical composition for treating cutaneous burns
CN202313829U (zh) 一次性使用踝关节背曲矫正器
RU2006126471A (ru) Способ лечения воспалительных заболеваний слюнных желез
Altman et al. Topical diclofenac sodium gel for knee osteoarthritis

Legal Events

Date Code Title Description
PSEA Patent sealed
RENW Renewal (renewal fees accepted)

Free format text: PATENT RENEWED FOR 3 YEARS UNTIL 03 FEB 2016 BY DENNEMEYER + CO

Effective date: 20140801

RENW Renewal (renewal fees accepted)

Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 03 FEB 2017 BY CPA GLOBAL

Effective date: 20151222

ASS Change of ownership

Owner name: FERRING B.V., NL

Effective date: 20160421

RENW Renewal (renewal fees accepted)

Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 03 FEB 2018 BY CPA GLOBAL

Effective date: 20161223

RENW Renewal (renewal fees accepted)

Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 03 FEB 2019 BY JAMES + WELLS

Effective date: 20180202

RENW Renewal (renewal fees accepted)

Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 03 FEB 2020 BY JAMES + WELLS

Effective date: 20190130

RENW Renewal (renewal fees accepted)

Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 03 FEB 2021 BY IPAN GMBH

Effective date: 20200120

RENW Renewal (renewal fees accepted)

Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 03 FEB 2022 BY IPAN GMBH

Effective date: 20210122

RENW Renewal (renewal fees accepted)

Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 03 FEB 2023 BY IPAN GMBH

Effective date: 20220120

RENW Renewal (renewal fees accepted)

Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 03 FEB 2024 BY IPAN GMBH

Effective date: 20230120

RENW Renewal (renewal fees accepted)

Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 03 FEB 2025 BY IPAN GMBH

Effective date: 20240122

LAPS Patent lapsed